The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.

Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ...

Eugene Braunwald, who was widely recognized as “ The Father of Modern Cardiology ,” died on April 22 at the age of 96. When I ...

The analysis estimated the drug companies’ pledge to offer all new drugs at most-favored nation pricing would save the U.S.

In this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI ...

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

Faced with stiff local opposition and a possible loss in court, PeaceHealth drops plan to replace Eugene Emergency Physicians ...

Marty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.

Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.

Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change health care are reasonable, but also self ...

According to CDC data, just over 13% of adults have reported using an anti-depressant. Last year, HHS released a report ...

His real name is Will Flanary, but you probably know him as Dr. Glaucomflecken — the internet’s go-to doctor/comedian. On ...